Delivery Order SPE2DB20D1109-SPE2DB23FP04U
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $1,242.64 for the provision of Lantus Solostar 100 unit/mL 3mL medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 29, 2021, with a completion date of September 30, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award, valued at $2,547.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award has a period of performance through March 27, 2024, and was not set aside for any specific business category....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The $8,165.04 Firm Fixed Price Delivery Order contract has a completion date of February 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,047.65 delivery order contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has a completion date of September 6, 2023 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,184.13 delivery order is for Lantus Solostar 100 unit/ml 3ml, a specialty medication. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FL39A) with a ceiling value of $1,016.82 placed by the Defense Logistics Agency (DLA). The award is for the provision of Lantus Solostar 100 unit/mL 3mL medication. The contract has a period of performance ending on May 16, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,940.64 for the pharmaceutical product Lantus Solostar 100 Unit/mL 3mL. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 26, 2022, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FS24B) for Lantus Solostar 100 unit/mL 3mL valued at $1,202.19. The award was made by the Defense Logistics Agency (DLA) on March 29, 2022, with a completion date of March 30, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $13,355.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty pharmaceutical product used for diabetes management. The award is a firm fixed-price delivery order with a completion date of February 13, 2024. The contract was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lantus Solostar 100 unit/mL 3mL prescription medication. The $1,853.34 firm fixed-price delivery order was awarded on December 14, 2022 by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 15, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP04UDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Lantus Solostar 100 Unit/ML 3ML, a specialty medication used for diabetes management. The firm-fixed-price delivery order, valued at $3,054.34, has a period of performance through May 2, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 5/1/23 |